Log In
Print
BCIQ
Print
Print this Print this
 

Altrazeal

  Manage Alerts
Collapse Summary General Information
Company Uluru Inc.
DescriptionAntimicrobial dressing incorporating the company's Nanoflex nanoparticle aggregate technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationWounds
Indication DetailsTreat wounds at skin graft donor sites
Regulatory Designation

Partner

Jiangxi Aiqilin Pharmaceuticals Group; Melmed Holdings AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today